Guidance
Human papillomavirus vaccines: WHO position paper, December 2022
This document replaces the 2014 WHO position paper on vaccines against diseases caused by human papillomaviruses (HPV). It focuses primarily on the prevention of cervical cancer, but also considers the broader
spectrum of cancers and other diseases preventable by HPV vaccination. It incorporates recent developments
concerning HPV vaccines, including the licensure of a nonavalent (9-valent) vaccine and recent data on vaccine
effectiveness, and provides guidance on the choice of vaccine. New recommendations are proposed regarding
vaccination strategies targeting girls only or both girls and boys, and vaccination of multiple birth cohorts. These recommendations were discussed by SAGE in October 2016. Evidence presented at the SAGE meeting can be accessed at: http://www.who.int/immunization/sage/meetings/2016/october/en/
.
Authors
Languages
- Arabic
- Chinese
- English
- French
- Russian
- Spanish
Type
Categories
Organisations
